Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

NCT: NCT07023666 · RECRUITING

NCT IDNCT07023666
StatusRECRUITING
Start Date2025-10-07
Completion2027-12-30
SponsorInova Health Care Services (OTHER)
First posted
Last updated

Brief Summary

This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑